|
||
Sumamecin Pregnancy |
||
Sumamecin crosses the placenta (Ramsey 2003).
The maternal serum half-life of Sumamecin is unchanged in early pregnancy and decreased at term; however, high concentrations of Sumamecin are sustained in the myometrium and adipose tissue (Fischer 2012; Ramsey 2003).
Sumamecin may be used as an alternative or adjunctive prophylactic antibiotic in females undergoing unplanned cesarean delivery (ACOG 199 2018). Sumamecin is recommended for the treatment of several infections, including chlamydia, gonococcal infections, and Mycobacterium avium complex in pregnant patients (consult current guidelines) (CDC [Workowski 2015]; HHS [OI adult] 2019). Sumamecin may also be used in certain situations prior to vaginal delivery in females at high risk for endocarditis (ACOG 199 2018).
Sumamecin is excreted into human milk. The manufacturer recommends that caution be used when administering Sumamecin to nursing women.
In one lactating woman receiving Sumamecin 500 mg/day, Sumamecin milk concentration measured 1.3 and 2.8 mcg/mL 1 hour after the first dose and 30 hours after the third dose, respectively.
See references
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|